文献速递肾癌与肾肿瘤

肾肿瘤血管中前列腺特异性膜抗原表达的综合评估:对影像学研究的启示及预后作用

Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.
PubMed 文献 · J Urol · 2017-08-19

研究纳入257例肾细胞癌患者(中位随访超过10.0年),采用免疫组化检测肿瘤血管中前列腺特异性膜抗原(PSMA)蛋白表达,并利用TCGA数据分析FOLH1 mRNA表达。结果显示透明细胞癌血管内皮PSMA表达高于乳头状和嫌色细胞癌,且与更高分级、分期、转移及致死性透明细胞癌相关;单因素和多因素分析显示内皮PSMA蛋白阳性与阴性强度与总生存显著相关。

要点

  • 透明细胞肾细胞癌血管内皮PSMA蛋白表达高于乳头状和嫌色细胞癌。
  • 透明细胞肾细胞癌中更高分级、分期、转移及致死病例的肿瘤血管PSMA表达更高。
  • TCGA分析支持血管FOLH1 mRNA的预后作用及PSMA影像在透明细胞癌中的有用性。

核心结论

  • 研究为透明细胞肾细胞癌患者进一步开发PSMA靶向影像提供了依据。
  • PSMA的预后作用在透明细胞肾细胞癌蛋白水平及透明细胞和乳头状肾细胞癌mRNA水平得到确定。

研究设计与样本

  • 研究纳入257例肾细胞癌患者,中位随访超过10.0年。
  • 采用免疫组化检测肿瘤血管上PSMA表达。
  • 利用TCGA数据研究透明细胞癌和乳头状肾细胞癌中FOLH1基因(PSMA)mRNA的血管表达。

主要发现

  • 内皮PSMA蛋白表达在透明细胞癌中高于乳头状和嫌色细胞癌。
  • 更高分级和分期、转移及致死性透明细胞肾细胞癌显示肿瘤血管中PSMA表达更高。
  • 单因素和多因素分析显示,内皮PSMA蛋白阳性与阴性表达强度与总生存显著相关。
  • 基于TCGA的分析证实了血管FOLH1 mRNA表达的预后作用。
  • 分析还支持PSMA影像在透明细胞癌病例中的有用性,但在乳头状肾细胞癌中不支持。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prostate specific membrane antigen is expressed by the endothelium of many tumors. The aim of the study was to find a rationale for prostate specific membrane antigen based imaging and investigate the prognostic role of vascular prostate specific membrane antigen expression in patients with renal cell carcinoma. MATERIALS AND METHODS: A total of 257 patients with renal cell carcinoma were included in study with a median followup exceeding 10.0 years. Prostate specific membrane antigen expression on tumor vessels was detected by immunohistochemistry. Vascular expression of FOLH1 gene (prostate specific membrane antigen) mRNA was investigated in clear cell carcinoma and papillary renal cell carcinoma using TCGA (The Cancer Genome Atlas) data. RESULTS: Endothelial prostate specific membrane antigen protein expression was higher in clear cell than in papillary and chromophobe renal cell carcinoma. Higher grade and stage, metastatic and lethal clear cell renal cell carcinoma showed higher prostate specific membrane antigen expression in tumor vessels. On univariate and multivariate analysis the intensity of positive vs negative endothelial prostate specific membrane antigen protein expression was significantly associated with overall survival. TCGA based analyses confirmed the prognostic role of vascular expression of FOLH1 mRNA. The analyses also supported the usefulness of prostate specific membrane antigen based imaging in cases of clear cell but not papillary renal cell carcinoma. CONCLUSIONS: We provide a rationale for further development of prostate specific membrane antigen targeted imaging in patients with clear cell renal cell carcinoma. The prognostic role of prostate specific membrane antigen was determined at the protein level in clear cell renal cell carcinoma and at the mRNA level in clear cell and papillary renal cell carcinoma.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Spatz S, Tolkach Y, Jung K, et al. Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role. J Urol. 2017. PMID: 28827104. doi:10.1016/j.juro.2017.08.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。